CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Top Biotech Industry Trends to Watch for in 2022

Top Biotech Industry Trends to Watch...

Encore Healthcare's VP of Clinical Operations Carrie Hylton-Proffitt, RRT Earns Accreditation with ACHC

Encore Healthcare's VP of Clinical...

Challenges Facing Biotech Companies Seeking Funding

Challenges Facing Biotech Companies...

How are Advancements in Biotechnology Help People Improve their Lives?

How are Advancements in Biotechnology...

Key Trends in Bioengineering to Watch for in 2022

Key Trends in Bioengineering to Watch...

How AI is Reshaping the Biotechnology Sector

How AI is Reshaping the Biotechnology...

Dr. Soren Thestrup-Nielsen M.D Joins Mainz Biomed's Strategic Advisory Board

Dr. Soren Thestrup-Nielsen M.D Joins...

The Use of Artificial Intelligence in the Biotechnology

The Use of Artificial Intelligence in...

Top Biotech Industry Trends to Watch for in 2022

Top Biotech Industry Trends to Watch...

Encore Healthcare's VP of Clinical Operations Carrie Hylton-Proffitt, RRT Earns Accreditation with ACHC

Encore Healthcare's VP of Clinical...

Challenges Facing Biotech Companies Seeking Funding

Challenges Facing Biotech Companies...

How are Advancements in Biotechnology Help People Improve their Lives?

How are Advancements in Biotechnology...

Key Trends in Bioengineering to Watch for in 2022

Key Trends in Bioengineering to Watch...

How AI is Reshaping the Biotechnology Sector

How AI is Reshaping the Biotechnology...

Dr. Soren Thestrup-Nielsen M.D Joins Mainz Biomed's Strategic Advisory Board

Dr. Soren Thestrup-Nielsen M.D Joins...

The Use of Artificial Intelligence in the Biotechnology

The Use of Artificial Intelligence in...

Gene Mack Positioned as the Chief Financial Officer at Imcyse

Life Sciences Review Life Sciences Review | Friday, November 26, 2021
Tweet

Gene Mack will contribute his profound understanding and skills of the financial sector to Imcyse as Chief Financial Officer, allowing the company to move forward with its groundbreaking solutions.


Fremont, CA: “I am excited to join Imcyse during this meaningful stage of scientific and corporate growth,” said Gene Mack. “The Company’s novel platform and clinical progress achieved to date uniquely positions Imcyse to deliver on near-term program milestones, and I look forward to working closely with Imcyses exceptionally talented and experienced team to bring revolutionary potential treatment options to patients.” Gene Mack has been named Chief Financial Officer at Imcyse.


Mr. Mack has more than 25 years of expertise in the life sciences industry, specialising in capital markets, business development, and corporate finance. Mr. Mack comes to Imcyse from OncoC4, a privately held biotechnology company that was formed when MSD acquired OncoImmune. He supervised OncoC4's financial establishment in addition to coordinating the successful transaction between the two companies.


 Mr. Mack has served as CFO for a number of biopharmaceutical firms in various stages of development and commercialization, raising approximately $150 million in IPO proceeds and other equity transactions in only the last three years. Mr. Mack provides a proven track record of success in the biotechnology industry, with over $600 million in M&A and licencing transactions to go along with his capital markets skills. Mr. Mack spent over fifteen years as a senior publishing analyst covering biotechnology and life sciences for a number of investment banks, including Gruntal & Co., Lazard, and HSBC, before switching to an operational CFO seven years ago. Gene graduated from Fordham University with a B.S. in Biochemistry and an MBA in Finance.


“We are thrilled to welcome Gene as our new CFO,” said Denis Bedoret, Ph.D., Chief Executive Officer of Imcyse. “Gene brings a deep knowledge and expertise of the financial sector, and I am confident that he will be an invaluable addition to our global executive management team as we work to pioneer the next generation of immunotherapeutics in autoimmune diseases.”


Weekly Brief

loading
Top 10 Biotech Startups Companies - 2022
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/gene-mack-positioned-as-the-chief-financial-officer-at-imcyse--nwid-644.html